Skip to main content
Gee-Chen Chang on Muck Rack

Gee-Chen Chang

As seen in: Nature, Wiley Online Library, PLOS, Cell Press, The Lancet, Future Medicine, European Journal of Cancer, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gee-Chen

Contact Gee-Chen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures

|
By Shankha Satpathy, Natalie Clark, Yi-Ju Chen, Noshad Hosseini, Ya-Hsuan Chang, Yi Hsiao, Jonathan T. Lei, Francesca Petralia, Jin-Shing Chen, Yifat Geffen, David Heiman, Indranil Paul, Hanbyul Cho, Michelle Hollenberg, Giacomo B Marino, Kuen-Tyng Lin, Rahul Mannan, C. White, Joe Allen, Shayan C. Avanessian, M. Kane, Ashley Wolfe, Wenke Liu, Shankara Anand, Mong-Wei Lin, Moe Haines, Erik Bergström, Grant A. Hussey, Ginny Xiaohe Li, Deepak Mani, Hao Fang, Eric J. Jaehnig, Hasmik Keshishian, Kang-Yi Su, Yi-Jing Hsiao, Hsao-Hsun Hsu, Min-Shu Hsieh, Kuo-Hsuan Hsu, Simone Gohsman, John R. Thorup, Yamei Deng, Yo Akiyama, Eden Z. Deng, Eric Chen, Azra Krek, Rodrigo Espinoza, Weiping Ma, Daniel Charytonowicz, Robert Sebra, Jyun-Hong Lin, Yin-Chen Hsu, Kun-Chieh Chen, Yu-Tai Wang, Alexander J. Lazar, Mehdi Mesri, Xu Zhang, Karl R. Clauser, David Fenyö, Arul M. Chinnaiyan, Bing Zhang, Kelly V. Ruggles, Chelsea Newton, Pei Wang, Galen Hostetter, Gilbert S. Omenn, Chandan Kumar-Sinha, Ramaswamy Govindan, Paul K. Paik, Abhijit Parolia, QING LI, Avi Ma’ayan, Gad Getz, Saravana M. Dhanasekaran, Ana I. Robles, Gee-Chen Chang, Pan-Chyr Yang, Sung-Liang Yu, Hsuan-Yu Chen, Alexey I. Nesvizhskii, Steven Carr, D.R. Mani, Marcin Cieslik, Yu-Ju Chen, Michael Gillette, Chao-Wen Lu, Cheng-Hsiang Chu, Chia-Li Han, Chien-Yu Lin, Ching-Wen Chen, Chung-Hsien Lin, Hsiang-En Hsu, Jia-Jun Wu, Pei-Hsing Chen, Pei-Rong Huang, Wan-Chun Lai, Xu-Heng Chiang, Ya-Ling Chang, Yan-Ming Chen, Yi-Ling Chen, Yi-Wen Wang, Yi-Wei Lin, Yu-Cheng Chang, Yu-Ting Huang, Zhe-Rong Zheng, Akhilesh Pandey, Alexander Pilozzi, Alex Webster, Amanda G. Paulovich, Andrew Godwin, Barbara L Pruetz, Bart O. Williams, Brian Druker, Daniel Rohrer, Daniel Chan, Danail Petrov, Elizabeth Duffy, George Wilson, Grace Zhao, Jan Lubinski, Jasmine Huang, Jason M. Hafron, Jeffrey W. Tyner, John M. Koomen, Maciej Wiznerowicz, Marcin Domagalski, Meenakshi Anurag, Nathan Edwards, Paul D Piehowski, Qin Li, Rafael Fonseca, Rashna Madan, Ross Bremner, Sandra López Cerdá, Shuang Cai, Tao Liu, Thomas A. Bauer, Xiaojun Jing, Yuping Zhang, Zoran Andrić, Miloni Kinarivala, Brecca Miller, Alexi Monovoukas, Yan-Si Chen, Ze-Shiang Lin, Chang-Wei Yeh, Eunkyung An, Mathangi Thiagarajan, Chi-Ya Shen, Chien-Chia Lin, Hsing-Jui Tsai, Jing-Wei Lin, Juani Waniwan, Ki-Hok Liao, Sin-Ming Huang, Tai-Ching Lin, Wei-Tzu Chiu, Yuju Lien, Abdul Samad Hashimi, Adrij Mohan, Aniket Dagar, David Chesla, Diwakar Davaar, Iga Kołodziejczak, Kakhaber Zaalishvili, Karen A. Ketchum, Melissa Borucki, Negin Vatanian, Pamela Grady, Popovici Bogdan, Ratna R. Thangudu, Reese Crispen, Ronald Matteotti, Sandra L. Cottingham, Shirley Tsang, William W. Maggio, Yvonne Shutack
| Cell Press Verified
Keywords proteogenomics lung adenocarcinoma genomics mass spectrometry PTMs biomarkers smokers never-smokers CPTAC ICPC Introduction Lung adenocarcinomas (LUAD), the most prevalent subtype of non-small cell lung cancers (NSCLC), represent a significant global health challenge with marked geographical and epidemiological diversity in incidence and disease progression.1 Despite advances in targeted therapies and improved diagnostic techniques, LUAD continue to exhibit high mortality rates,2...
Open in Who Shared Issue with article?

Optimizing management of stage IV EGFR mutant non‐small cell lung cancer in Asia: An expert opinion

|
By Gee-Chen Chang, Akhil Kapoor, Chee Khoon Lee, Chunxia Su
| Wiley Online Library Verified
ADCs Antibody-Drug Conjugates AEs Adverse Events ALK Anaplastic Lymphoma Kinase ctDNA Circulating Tumour DNA EGFR Epidermal Growth Factor Receptor EGFRm Epidermal Growth Factor Receptor Mutant ESMO European Society For Medical Oncology IHC Immunohistochemistry IV Intravenous MET Mesenchymal Epithelial Transition NGS Next-Generation Sequencing NSCLC Non-Small Cell Lung Cancer NTRK Neurotrophic Tyrosine Receptor Kinase OS Overall Survival PCR Polymerase Chain Reaction PD-L1 Programmed...
Open in Who Shared Issue with article?

Trouble with promoting lung cancer screening in never-smokers - Authors' reply

|
By Chao-Hua Chiu, Chong-Jen Yu, Gee-Chen Chang, Pan-Chyr Yang
| The Lancet Verified
The TALENT study is the first prospective low-dose CT (LDCT) lung cancer screening study in never-smokers. Therefore, it is not surprising to express concerns. We appreciate the valuable feedback in the Correspondence by Wayne Gao and H Gilbert Welch 1 Trouble with promoting lung cancer screening in never-smokers. ; however, it is essential to clarify several misconceptions.
Open in Who Shared Issue with article?
See all 10 articles